The Silver Spring, Md.-based company posted profits of $178.6 million, or $3.89 per share, on sales of $370.5 million for the 3 months ended March 31, for bottom-line loss of -24% on sales growth of 0.4% compared with the same period last year.
Get the full story at our sister site, Drug Delivery Business News.
The post United Therapeutics misses estimates for Q1 rev, earnings appeared first on MassDevice.
from MassDevice http://ift.tt/2p3SZCb
Cap comentari:
Publica un comentari a l'entrada